First Time Loading...

Adamis Pharmaceuticals Corp
NASDAQ:ADMP

Watchlist Manager
Adamis Pharmaceuticals Corp Logo
Adamis Pharmaceuticals Corp
NASDAQ:ADMP
Watchlist
Price: 0.4901 USD -2.97% Market Closed
Updated: May 8, 2024

Adamis Pharmaceuticals Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Adamis Pharmaceuticals Corp
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Adamis Pharmaceuticals Corp
NASDAQ:ADMP
Revenue
$4.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Revenue
$85.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$45.5B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$55.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$61.4B
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Revenue
$35.9B
CAGR 3-Years
12%
CAGR 5-Years
11%
CAGR 10-Years
5%

See Also

What is Adamis Pharmaceuticals Corp's Revenue?
Revenue
4.8m USD

Based on the financial report for Dec 31, 2022, Adamis Pharmaceuticals Corp's Revenue amounts to 4.8m USD.

What is Adamis Pharmaceuticals Corp's Revenue growth rate?
Revenue CAGR 1Y
115%

Over the last year, the Revenue growth was 115%.